Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 4
Submit an article Journal homepage
133
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature

Martina Muttia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Stefano Cordellaa Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Angelica Parisottoa Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Francesca Bettellia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Monica Morsellia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Angela Cuoghia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Paola Bresciania Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Andrea Messerottia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Andrea Giliolia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Valeria Piolia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Davide Giustia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Elisabetta Colacia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Luca Cassanellia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Ambra Paolinib Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Silvia Martinellib Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Rossana Maffeib Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyORCID Iconhttps://orcid.org/0000-0002-3518-2006View further author information
ORCID Icon,
Giovanni Rivab Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Vincenzo Nasillob Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Mario Sartib Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Tommaso Trentib Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Patrizia Comolic Pediatric Hematology/Oncology Unit and Cell Factory, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo, Pavia, ItalyView further author information
,
Enrico Tagliaficob Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics, Azienda Ospedaliero-Universitaria di Modena/Unità Sanitaria Locale di Modena, Modena, ItalyView further author information
,
Rossella Manfredinid Department of Life Sciences, Center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia, Modena, ItalyView further author information
,
Albino Ecchere Department of Medical and Surgical Sciences, Institute of Pathology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Ivana Lagrecaa Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Patrizia Barozzia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Leonardo Potenzaa Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Roberto Marascaa Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Anna Candonia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyView further author information
,
Mario Luppia Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyCorrespondence[email protected]
View further author information
&
Fabio Forghieria Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria di Modena, Modena, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 511-515 | Received 05 Oct 2023, Accepted 09 Dec 2023, Published online: 19 Dec 2023

References

  • Falini B, Nicoletti I, Martelli MF, et al. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc + AML): biologic and clinical features. Blood. 2007;109(3):874–885. doi:10.1182/blood-2006-07-012252
  • Falini B, Brunetti L, Sportoletti P, et al. NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood. 2020;136(15):1707–1721. doi:10.1182/blood.2019004226
  • Fournier E, Heiblig M, Lespinasse C, et al. Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group. Leukemia. 2022;36(5):1390–1400. doi:10.1038/s41375-022-01534-z
  • Koh Y, Park J, Bae EK, et al. Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype. Int J Hematol. 2009;90(1):1–5. doi:10.1007/s12185-009-0350-1
  • Park BG, Chi HS, Park SJ, et al. Clinical implications of non-A-type NPM1 and FLT3 mutations in patients with normal karyotype acute myeloid leukemia. Acta Haematol. 2012;127(2):63–71. doi:10.1159/000331509
  • Pastore F, Greif PA, Schneider S, et al. The NPM1 mutation type has no impact on survival in cytogenetically normal AML. PLOS One. 2014;9(10):e109759. doi:10.1371/journal.pone.0109759
  • Selim D, Alonzo TA, Othus M, et al. Genomic subtypes of nucleophosmin (NPM1) mutations are associated with clinical outcome in AML – a COG and SWOG intergroup collaboration. Blood. 2016;128(22):285. doi:10.1182/blood.V128.22.285.285
  • Alpermann T, Schnittger S, Eder C, et al. Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia. Haematologica. 2016;101(2):e57–e58. doi:10.3324/haematol.2015.133819
  • Heiblig M, Sujobert P, Hayette S, et al. Impact of NPM1 mutation subtype on treatment outcome in AML: the Lyon-University Hospital experience. Leuk Res. 2019;76:29–32. doi:10.1016/j.leukres.2018.11.016
  • Sciumè M, Fabris S, Ciceri G, et al. Clinical impact of NPM1 mutation subtypes in a monocentric cohort of acute myeloid leukemia. Ann Hematol Oncol. 2020;7:1296.
  • Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on the behalf of the ELN. Blood. 2022;140(12):1345–1377. doi:10.1182/blood.2022016867
  • Boddu P, Kantarjian H, Borthakur G, et al. Co-occurrence of FLT3-TKD and NPM1 mutations defines a highly favorable prognostic AML group. Blood Adv. 2017;1(19):1546–1550. doi:10.1182/bloodadvances.2017009019
  • Balsat M, Renneville A, Thomas X, et al. Postinduction minimal residual disease predicts outcome and benefit from allogeneic stem cell transplantation in acute myeloid leukemia with NPM1 mutation: a study by the acute leukemia French Association Group. J Clin Oncol. 2017;35(2):185–193. doi:10.1200/JCO.2016.67.1875
  • Lesieur A, Thomas X, Nibourel O, et al. Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use. Haematologica. 2021;106(6):1767–1769. doi:10.3324/haematol.2020.260133
  • Heuser M, Freeman SD, Ossenkoppele GJ, et al. 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party. Blood. 2021;138(26):2753–2767. doi:10.1182/blood.2021013626

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.